Fig. 2.
Survival curves for patients with COVID-19 and cytokine release syndrome that did not receive anticytokine treatment (Control group) and received tofacitinib (Tofacitinib group).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.